Merck (MRK) Current Deferred Tax Assets (2016 - 2023)
Historic Current Deferred Tax Assets for Merck (MRK) over the last 15 years, with Q2 2023 value amounting to $6.6 billion.
- Merck's Current Deferred Tax Assets fell 251.1% to $6.6 billion in Q2 2023 from the same period last year, while for Jun 2023 it was $6.6 billion, marking a year-over-year decrease of 251.1%. This contributed to the annual value of $7.2 billion for FY2022, which is 260.48% up from last year.
- Per Merck's latest filing, its Current Deferred Tax Assets stood at $6.6 billion for Q2 2023, which was down 251.1% from $6.7 billion recorded in Q1 2023.
- Merck's 5-year Current Deferred Tax Assets high stood at $7.2 billion for Q3 2022, and its period low was $3.2 billion during Q1 2019.
- Moreover, its 5-year median value for Current Deferred Tax Assets was $6.0 billion (2021), whereas its average is $5.6 billion.
- Per our database at Business Quant, Merck's Current Deferred Tax Assets tumbled by 2137.65% in 2019 and then skyrocketed by 4948.65% in 2021.
- Over the past 5 years, Merck's Current Deferred Tax Assets (Quarter) stood at $4.3 billion in 2019, then increased by 9.28% to $4.7 billion in 2020, then soared by 49.49% to $7.0 billion in 2021, then rose by 2.6% to $7.2 billion in 2022, then decreased by 7.39% to $6.6 billion in 2023.
- Its Current Deferred Tax Assets was $6.6 billion in Q2 2023, compared to $6.7 billion in Q1 2023 and $7.2 billion in Q4 2022.